Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
PepGen is empowering nucleic acid therapeutics to go the distance.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Perceptive Advisors has invested in 226 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Cidara Therapeutics received $339.0M in a Grant round. Perceptive Advisors's total known invested capital is $30.3B.
Perceptive Advisors's average investment size is $134.2M across its portfolio of 226 companies.
Recent Perceptive Advisors portfolio additions include Yarrow, Contineum Therapeutics, Fulcrum Therapeutics, Crescent Biopharma, TELA Bio. These companies were founded in 2020 or later.